BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28752891)

  • 21. N-glycosylation gene DPAGT1 is a target of the Wnt/beta-catenin signaling pathway.
    Sengupta PK; Bouchie MP; Kukuruzinska MA
    J Biol Chem; 2010 Oct; 285(41):31164-73. PubMed ID: 20693288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential modulation of TCF/LEF-1 activity by the soluble LRP6-ICD.
    Beagle B; Johnson GV
    PLoS One; 2010 Jul; 5(7):e11821. PubMed ID: 20676368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.
    Ishitani T; Ninomiya-Tsuji J; Matsumoto K
    Mol Cell Biol; 2003 Feb; 23(4):1379-89. PubMed ID: 12556497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. VBP1 modulates Wnt/β-catenin signaling by mediating the stability of the transcription factors TCF/LEFs.
    Zhang H; Rong X; Wang C; Liu Y; Lu L; Li Y; Zhao C; Zhou J
    J Biol Chem; 2020 Dec; 295(49):16826-16839. PubMed ID: 32989053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WNT signalling: mechanisms and therapeutic opportunities.
    Schulte G; Bryja V
    Br J Pharmacol; 2017 Dec; 174(24):4543-4546. PubMed ID: 29235106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wnt/β-catenin signalling in adrenal physiology and tumour development.
    Berthon A; Martinez A; Bertherat J; Val P
    Mol Cell Endocrinol; 2012 Mar; 351(1):87-95. PubMed ID: 21930188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia.
    Simon M; Grandage VL; Linch DC; Khwaja A
    Oncogene; 2005 Mar; 24(14):2410-20. PubMed ID: 15735743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Yin-Yang of TCF/beta-catenin signaling.
    Barker N; Morin PJ; Clevers H
    Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. β-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors.
    Grumolato L; Liu G; Haremaki T; Mungamuri SK; Mong P; Akiri G; Lopez-Bergami P; Arita A; Anouar Y; Mlodzik M; Ronai ZA; Brody J; Weinstein DC; Aaronson SA
    PLoS Genet; 2013; 9(8):e1003603. PubMed ID: 23966864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of ICAT highlights a role for catenin-mediated canonical Wnt signalling in early T cell development.
    Pongracz JE; Parnell SM; Jones T; Anderson G; Jenkinson EJ
    Eur J Immunol; 2006 Sep; 36(9):2376-83. PubMed ID: 16897815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology.
    Kagey MH; He X
    Br J Pharmacol; 2017 Dec; 174(24):4637-4650. PubMed ID: 28574171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β-Catenin-dependent pathway activation by both promiscuous "canonical" WNT3a-, and specific "noncanonical" WNT4- and WNT5a-FZD receptor combinations with strong differences in LRP5 and LRP6 dependency.
    Ring L; Neth P; Weber C; Steffens S; Faussner A
    Cell Signal; 2014 Feb; 26(2):260-7. PubMed ID: 24269653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-catenin/T-cell factor-mediated transcription is modulated by cell density in human bronchial epithelial cells.
    Steel MD; Puddicombe SM; Hamilton LM; Powell RM; Holloway JW; Holgate ST; Davies DE; Collins JE
    Int J Biochem Cell Biol; 2005 Jun; 37(6):1281-95. PubMed ID: 15778091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1).
    Asally M; Yoneda Y
    Exp Cell Res; 2005 Aug; 308(2):357-63. PubMed ID: 15936755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
    Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
    Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sox17 modulates Wnt3A/beta-catenin-mediated transcriptional activation of the Lef-1 promoter.
    Liu X; Luo M; Xie W; Wells JM; Goodheart MJ; Engelhardt JF
    Am J Physiol Lung Cell Mol Physiol; 2010 Nov; 299(5):L694-710. PubMed ID: 20802155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner.
    Notani D; Gottimukkala KP; Jayani RS; Limaye AS; Damle MV; Mehta S; Purbey PK; Joseph J; Galande S
    PLoS Biol; 2010 Jan; 8(1):e1000296. PubMed ID: 20126258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visualization and exploration of Tcf/Lef function using a highly responsive Wnt/β-catenin signaling-reporter transgenic zebrafish.
    Shimizu N; Kawakami K; Ishitani T
    Dev Biol; 2012 Oct; 370(1):71-85. PubMed ID: 22842099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signalling activity of beta-catenin targeted to different subcellular compartments.
    Hagen T; Sethi JK; Foxwell N; Vidal-Puig A
    Biochem J; 2004 Apr; 379(Pt 2):471-7. PubMed ID: 14733614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lef/Tcf-dependent Wnt/beta-catenin signaling during Xenopus axis specification.
    Geng X; Xiao L; Lin GF; Hu R; Wang JH; Rupp RA; Ding X
    FEBS Lett; 2003 Jul; 547(1-3):1-6. PubMed ID: 12860376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.